Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank86
3Y CAGR-5.0%
5Y CAGR+1.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-5.0%/yr
vs +10.5%/yr prior
5Y CAGR
+1.8%/yr
Recent deceleration
Acceleration
-15.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $149.19M | +9.3% |
| 2024 | $136.44M | +4.7% |
| 2023 | $130.26M | -25.2% |
| 2022 | $174.04M | +8.3% |
| 2021 | $160.65M | +17.5% |
| 2020 | $136.70M | +7.2% |
| 2019 | $127.47M | +9.0% |
| 2018 | $116.91M | +39.0% |
| 2017 | $84.10M | -6.7% |
| 2016 | $90.12M | - |